Pure Global AI
NCT06135324Not yet recruiting

Impairments That Affect Correct Inhaler Use in COPD

Prevalence of Impairments in Cognitive Function and Manual Dexterity in Out-patients With COPD and Associations With Correct Inhaler Techniques (INHALE)
COPD FoundationClinicalTrials.gov
Verified
Study focus
Disease/Condition
COPD
Study type
Observational
Sponsor & location
Primary sponsor
COPD Foundation
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Jul 19, 2025
Enrollment
500 participants
Primary outcome

Prevalence,Errors using inhaler devices

Summary

INHALE is a one-year, multi-site observational research study funded by Viatris, with two
 aims:
 
 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in
 stable out-patients with chronic obstructive pulmonary disease (COPD).
 
 2. Assess the relationship of cognitive impairment and impaired manual dexterity with
 patient errors using current pMDIs, SMIs and/or DPIs.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06135324
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06135324 through Pure Global AI's free database. This phase not specified trial is sponsored by COPD Foundation and is currently Not yet recruiting. The study focuses on COPD. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.